Bionano to Participate in the H.C. Wainwright @ Home Event

SAN DIEGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the H.C. Wainwright @ Home Event on Wednesday, October 15^th, 2025.

Conference & Webcast Details

A replay / recording of the session will be available following the conference through the Bionano website at ir.bionano.com for at least 90 days.

About Bionano

Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. The Company also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.

For more information, visit www.bionano.com or www.bionanolaboratories.com.

Bionano’s products are for research use only and not for use in diagnostic procedures.

Contacts

Company Contact:

Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
[email protected]

Investor Relations:

Kelly Gura
Gilmartin Group
+1 (212) 229-6163
[email protected]

You May Also Be Interested In

• Three new directors elected to Scoular’s Board of Directors
• Trump Coin Price Prediction: A $2.50 Recovery Target Meets Remittix’s $0.46 Final Presale Stage
• Remittix News: 1,000 Holders Gain PayFi App Access Ahead of the November 24 RTX Launch